European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment.

Jürgen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Vito Franco; Emanuela Boveri; Umberto Gianelli; Heinz Gisslinger; Francesco Passamonti; Ayalew Tefferi; Tiziano Barbui

doi:10.3324/haematol.2011.061432

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment.

Jürgen Thiele, Attilio Orazi, Hans Michael Kvasnicka, Vito Franco, Emanuela Boveri, Umberto Gianelli, Heinz Gisslinger, Francesco Passamonti, Ayalew Tefferi, Tiziano Barbui

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Haematologica
Volume	97
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2011.061432
Publication status	Published - Mar 2012

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2011.061432

Cite this

Thiele, J., Orazi, A., Kvasnicka, H. M., Franco, V., Boveri, E., Gianelli, U., Gisslinger, H., Passamonti, F., Tefferi, A., & Barbui, T. (2012). European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment. Haematologica, 97(3). https://doi.org/10.3324/haematol.2011.061432

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3) : 360-5--comment. / Thiele, Jürgen; Orazi, Attilio; Kvasnicka, Hans Michael et al.

In: Haematologica, Vol. 97, No. 3, 03.2012.

Research output: Contribution to journal › Article › peer-review

Thiele, J, Orazi, A, Kvasnicka, HM, Franco, V, Boveri, E , Gianelli, U, Gisslinger, H, Passamonti, F, Tefferi, A & Barbui, T 2012, 'European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment.', Haematologica, vol. 97, no. 3. https://doi.org/10.3324/haematol.2011.061432

@article{43cf71bc9c5c4253aed936bd0f7cd72d,

title = "European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment.",

author = "J{\"u}rgen Thiele and Attilio Orazi and Kvasnicka, {Hans Michael} and Vito Franco and Emanuela Boveri and Umberto Gianelli and Heinz Gisslinger and Francesco Passamonti and Ayalew Tefferi and Tiziano Barbui",

year = "2012",

month = mar,

doi = "10.3324/haematol.2011.061432",

language = "English",

volume = "97",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "3",

}

TY - JOUR

T1 - European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3)

T2 - 360-5--comment.

AU - Thiele, Jürgen

AU - Orazi, Attilio

AU - Kvasnicka, Hans Michael

AU - Franco, Vito

AU - Boveri, Emanuela

AU - Gianelli, Umberto

AU - Gisslinger, Heinz

AU - Passamonti, Francesco

AU - Tefferi, Ayalew

AU - Barbui, Tiziano

PY - 2012/3

Y1 - 2012/3

UR - http://www.scopus.com/inward/record.url?scp=84863598232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863598232&partnerID=8YFLogxK

U2 - 10.3324/haematol.2011.061432

DO - 10.3324/haematol.2011.061432

M3 - Article

C2 - 22383744

AN - SCOPUS:84857775547

SN - 0390-6078

VL - 97

JO - Haematologica

JF - Haematologica

IS - 3

ER -

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3): 360-5--comment.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this